Josefsson, S. E., Huse, K., Kolstad, A., Beiske, K., Pende, D., Steen, C. B., . . . Myklebust, J. H. (2017). T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling. Clin Cancer Res.
Citação norma ChicagoJosefsson, Sarah E., et al. "T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized By Reversible Suppression of T-cell Receptor Signaling." Clin Cancer Res 2017.
MLA CitationJosefsson, Sarah E., et al. "T Cells Expressing Checkpoint Receptor TIGIT Are Enriched in Follicular Lymphoma Tumors and Characterized By Reversible Suppression of T-cell Receptor Signaling." Clin Cancer Res 2017.